Pharmacokinetics and pharmacodynamics of a fixed-dose combination of gemigliptin/metformin sustained release 25/500 mg compared to the loose combination in healthy male subjects.
Translational and clinical pharmacology（2020）
摘要
ClinicalTrials.gov Identifier: NCT03355014.
更多查看译文
关键词
Fixed-dose combination,Gemigliptin,Metformin
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要